Taghi Manshouri

7943332, May 17, 2011

Apr 16, 2010

12/761903

Maher Albitar - Sugarland TX, US
Michael J. Keating - Houston TX, US
Taghi Manshouri - Houston TX, US

Board of Regents, the University of Texas System - Austin TX

G01N 31/00
G01N 33/53

435 721, 435 71, 436 1, 436501, 436518, 424 91, 424520, 422 1, 422 50, 530300, 530350

The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

8114618, Feb 14, 2012

Apr 5, 2011

13/080180

Maher Albitar - Sugarland TX, US
Michael J. Keating - Houston TX, US
Taghi Manshouri - Houston TX, US

Board of Regents of the University of Texas System - Austin TX

G01N 31/00

435 721, 435 4, 435 71, 4352879, 436501, 436518, 436525, 436529, 436535, 436809, 427287, 427337, 427338, 530300, 530350

The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

8232068, Jul 31, 2012

Jan 12, 2012

13/349170

Maher Albitar - Sugarland TX, US
Michael J. Keating - Houston TX, US
Taghi Manshouri - Houston TX, US

Board of Regents, The University of Texas System - Austin TX

G01N 31/00
G01N 33/53

435 721, 435 4, 435 71, 4352879, 436501, 436518, 436525, 436529, 436535, 436809, 427287, 427337, 427338, 530300, 530350

The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

8501423, Aug 6, 2013

Jul 6, 2012

13/543560

Maher Albitar - Sugar Land TX, US
Michael J. Keating - Houston TX, US
Taghi Manshouri - Houston TX, US

Board of Regents, The University of Texas System - Austin TX

G01N 31/00
G01N 33/53

435 721, 435 4, 435 71, 4352879, 436501, 436518, 427287, 427337, 427338, 530300, 530350

The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

20030068664, Apr 10, 2003

Sep 20, 2002

10/251144

Maher Albitar - Sugarland TX, US
Michael Keating - Houston TX, US
Taghi Manshouri - Houston TX, US

Board of Regents, The University of Texas System

G01N033/53
G01N033/537
G01N033/543

435/007920

The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.

20140011215, Jan 9, 2014

Jul 3, 2013

13/934940

Michael J. KEATING - Houston TX, US
Taghi MANSHOURI - Houston TX, US

Board of Regents, The University of Texas System - Austin TX

G01N 33/68

435 723, 435 792, 435 79

The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.